In a Recent STAMPEDE Trial showed that men with newly diagnosed Metastatic Prostate Cancer showed that if local therapy is delivered to the prostate survival is improved in subset of patients with low metastatic burden.
A large retrospective population-based study (SEER) found that five-year overall survival might be improved if local therapy is administered. Another retrospective study using a different database NCDB saw improvement in overall survival when Metastatic Prostate patients were treated with prostate Radiation.
In summary, this large trial study demonstrated that treating the prostate with radiation in patients with metastatic prostate cancer has an overall survival benefit for patients with low volume disease
Dr. Mark Quinn
Board Certified Radiation Oncologist